An Interview from the 2016 EHA with Dr. Jeffrey Jones on the Role of Venetoclax in CLL
Friends,
I’m reporting to you on the first day of ASH. Chronic lymphocytic leukemia continues to be a hot topic with dozens of abstracts being presented today in both oral sessions and poster sessions. Here’s a quick summary from the morning.
Every once in a while, something happens that let’s you know that what we’re doing at the CLL Society is really having an impact. It just made my day. Take a look.
More to come tomorrow.
Brian Koffman, MD 12/3/16
Related posts